Cryoport Signs New Supply Chain Solutions Agreement with Boston IVF to Support Reproductive Material Shipments Across the U.S.
Cryoport Inc., a global provider of temperature-controlled supply chain solutions to the life sciences industry focused on the pharmaceutical and cell and gene therapy markets, has entered a new strategic partnership with Syneos Health, a fully integrated biopharmaceutical solutions organization.
Cryoport Inc., a leader in temperature-controlled supply chain solutions for the life sciences industry, has entered into a strategic relationship with BioLife Plasma Services, part of the global biopharmaceutical company Takeda, intended to provide consistent, high-quality cellular starting material for use in the manufacture of life-saving cellular therapies.
Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, and Mitsubishi Logistics Corporation, a leading Japanese pharma logistics company, have announced a multi-year strategic business alliance to create an integrated regenerative medicine supply chain partnership in Japan.